Arrowhead Pharmaceuticals Inc. (ARWR) Posts FY21 Loss of $1.36/Share
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $79.90 --0%
EPS Growth %: +4.8%
Financial Fact:
Loss on sale of fixed assets, net: 0
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +4.8%
Financial Fact:
Loss on sale of fixed assets, net: 0
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported FY 2021 EPS of ($1.36), versus ($0.84) last year.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Darden Restaurants (DRI) PT Raised to $235 at Guggenheim
- FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
